Severe eosinophilic asthma in Chinese C‐BIOPRED asthma cohort
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Clinical and Translational Medicine - 12(2022), 2, Seite n/a-n/a |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qingling Zhang [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Blood eosinophil count |
---|
doi: |
10.1002/ctm2.710 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ01794595X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ01794595X | ||
003 | DE-627 | ||
005 | 20230502074126.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ctm2.710 |2 doi | |
035 | |a (DE-627)DOAJ01794595X | ||
035 | |a (DE-599)DOAJ83b85c4f15734062aba00ab8ebbc8ee0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a R5-920 | |
100 | 0 | |a Qingling Zhang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe eosinophilic asthma in Chinese C‐BIOPRED asthma cohort |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
650 | 4 | |a blood eosinophil count | |
650 | 4 | |a cigarette smoking | |
650 | 4 | |a exacerbations | |
650 | 4 | |a fractional exhaled nitric oxide | |
650 | 4 | |a severe asthma | |
653 | 0 | |a Medicine (General) | |
700 | 0 | |a Xiuhua Fu |e verfasserin |4 aut | |
700 | 0 | |a Changzheng Wang |e verfasserin |4 aut | |
700 | 0 | |a Huahao Shen |e verfasserin |4 aut | |
700 | 0 | |a Lei Zhu |e verfasserin |4 aut | |
700 | 0 | |a Guochao Shi |e verfasserin |4 aut | |
700 | 0 | |a Zhongmin Qiu |e verfasserin |4 aut | |
700 | 0 | |a Zhongguang Wen |e verfasserin |4 aut | |
700 | 0 | |a Wei Gu |e verfasserin |4 aut | |
700 | 0 | |a Wei Luo |e verfasserin |4 aut | |
700 | 0 | |a Lina Zhao |e verfasserin |4 aut | |
700 | 0 | |a Yunqin Chen |e verfasserin |4 aut | |
700 | 0 | |a Sam Lim |e verfasserin |4 aut | |
700 | 0 | |a Chang Xiao |e verfasserin |4 aut | |
700 | 0 | |a Jian Kang |e verfasserin |4 aut | |
700 | 0 | |a Yunhui Zhang |e verfasserin |4 aut | |
700 | 0 | |a Mao Huang |e verfasserin |4 aut | |
700 | 0 | |a Jinfu Xu |e verfasserin |4 aut | |
700 | 0 | |a Kewu Huang |e verfasserin |4 aut | |
700 | 0 | |a Qiang Li |e verfasserin |4 aut | |
700 | 0 | |a Xiangyan Zhang |e verfasserin |4 aut | |
700 | 0 | |a Jianping Zhao |e verfasserin |4 aut | |
700 | 0 | |a Xiaoxia Liu |e verfasserin |4 aut | |
700 | 0 | |a Shenghua Sun |e verfasserin |4 aut | |
700 | 0 | |a Huaping Tang |e verfasserin |4 aut | |
700 | 0 | |a Bei He |e verfasserin |4 aut | |
700 | 0 | |a Shaoxi Cai |e verfasserin |4 aut | |
700 | 0 | |a Ping Chen |e verfasserin |4 aut | |
700 | 0 | |a Chunhua Wei |e verfasserin |4 aut | |
700 | 0 | |a Guangfa Wang |e verfasserin |4 aut | |
700 | 0 | |a Ping Chen |e verfasserin |4 aut | |
700 | 0 | |a Lixin Xie |e verfasserin |4 aut | |
700 | 0 | |a Jiangtao Lin |e verfasserin |4 aut | |
700 | 0 | |a Yuling Tang |e verfasserin |4 aut | |
700 | 0 | |a Zhihai Han |e verfasserin |4 aut | |
700 | 0 | |a Kian Fan Chung |e verfasserin |4 aut | |
700 | 0 | |a Nanshan Zhong |e verfasserin |4 aut | |
700 | 0 | |a the C‐BIOPRED consortium |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Clinical and Translational Medicine |d Wiley, 2013 |g 12(2022), 2, Seite n/a-n/a |w (DE-627)DOAJ000049395 |x 20011326 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g number:2 |g pages:n/a-n/a |
856 | 4 | 0 | |u https://doi.org/10.1002/ctm2.710 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/83b85c4f15734062aba00ab8ebbc8ee0 |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1002/ctm2.710 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2001-1326 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |e 2 |h n/a-n/a |